abstract |
The present invention is a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Peptide compound of Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH About the use of. Furthermore, the present invention relates to Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp- A peptide of OH and optionally at least one pharmaceutically acceptable carrier, at least one cryoprotectant, at least one dispersion protectant, at least one excipient and / or at least one diluent. Containing pharmaceutical compositions, preferably in the form of lyophilizates, buffers, artificial breast milk formulations, or breast milk substitutes. |